Johnson & Johnson (BKK:JNJ03)

Market Cap	14.76T
Revenue (ttm)	2.95T
Net Income (ttm)	738.27B
Shares Out	n/a
EPS (ttm)	304.09
PE Ratio	19.99
Forward PE	17.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	223,820
Average Volume	260,586
Open	3.080
Previous Close	3.080
Day's Range	3.040 - 3.120
52-Week Range	3.000 - 3.120
Beta	n/a
RSI	n/a
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: JNJ03

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD